Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Non-Current Debt (2016 - 2025)

Immucell's Non-Current Debt history spans 16 years, with the latest figure at $7.5 million for Q4 2025.

  • For Q4 2025, Non-Current Debt fell 17.17% year-over-year to $7.5 million; the TTM value through Dec 2025 reached $7.5 million, down 17.17%, while the annual FY2025 figure was $7.5 million, 17.17% down from the prior year.
  • Non-Current Debt reached $7.5 million in Q4 2025 per ICCC's latest filing, down from $7.9 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $10.9 million in Q3 2023 to a low of $7.5 million in Q4 2025.
  • Average Non-Current Debt over 5 years is $9.1 million, with a median of $9.0 million recorded in 2023.
  • Peak YoY movement for Non-Current Debt: grew 16.78% in 2022, then dropped 17.17% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $8.3 million in 2021, then grew by 10.38% to $9.2 million in 2022, then grew by 14.68% to $10.5 million in 2023, then decreased by 14.23% to $9.0 million in 2024, then dropped by 17.17% to $7.5 million in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Non-Current Debt are $7.5 million (Q4 2025), $7.9 million (Q3 2025), and $8.3 million (Q2 2025).